Прилучный С. В., Фурминская Е. Ю.

ФГБУ «Центральная клиническая больница с поликлиникой» Управления делами Президента Российской Федерации; Россия, 121359 Москва, ул. Маршала Тимошенко, 15

1. Pitman M., Centeno B., Reid M. et al. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology. Acta Cytologica 2022:1–17. DOI: 10.1159/000527912

2. International Academy of Cytology – International Agency for Research on Cancer – World Health Organization Joint Editorial Board. WHO Reporting System for Pancreaticobiliary Cytopathology. Lyon France: International Agency for Research on Cancer, 2022. Available at: https://tumourclassification.iarc. who.int/chapters/50.

3. Smith A.L., Abdul-Karim F.W., Goyal A. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathol 2016;124(4):285–93. DOI: 10.1002/cncy.21657

4. Hoda R.S., Finer E.B., Arpin R.N. et al. Risk of malignancy in the categories of the Papanicolaou Society of Cytopathology system for reporting pancreaticobiliary cytology. J Am Soc Cytopathol 2019;8(3):120–7. DOI: 10.1016/j.jasc.2019.01.002

5. Sung S., Del Portillo A., Gonda T.A. et al. Update on risk stratification in the Papanicolaou Society of Cytopathology System for Reporting Pancreaticobiliary Cytology categories: 3-Year, prospective, single-institution experience. Cancer Cytopathol 2020;128(1):29–35. DOI: 10.1002/cncy.22199

6. Hoda R.S., Arpin R.N., Rosenbaum M.W., Pitman M.B. Risk of malignancy associated with diagnostic categories of the proposed World Health Organization International System for Reporting Pancreaticobiliary Cytopathology. Cancer Cytopathol 2022;130(3):195–201. DOI: 10.1002/cncy.22514

7. Vandervoort J., Soetikno R.M., Montes H. et al. Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct. Gastrointest Endosc 1999;49(3 Pt 1):322–7. DOI: 10.1016/ s0016-5107(99)70008-8

8. Chadwick B.E., Layfield L.J., Witt B.L. et al. Significance of atypia in pancreatic and bile duct brushings: follow-up analysis of the categories atypical and suspicious for malignancy. Diagn Cytopathol 2014;42(4):285–91. DOI: 10.1002/dc.23035

9. Dudley J.C., Zheng Z., McDonald T. et al. Next-generation sequencing and fluorescence in situ hybridization have comparable performance characteristics in the analysis of pancreaticobiliary brushings for malignancy. J Mol Diagn 2016;18(1):124–30. DOI: 10.1016/j.jmoldx.2015.08.002

10. Yeo M.K., Kim K.H., Lee Y.M. et al. The usefulness of adding p53 immunocytochemistry to bile drainage cytology for the diagnosis of malignant biliary strictures. Diagn Cytopathol 2017;45(7):592–7. DOI: 10.1002/dc.23729

11. Poller D.N., Schmitt F. Should uncertainty concerning the risk of malignancy be included in diagnostic (nongynecologic) cytopathology reports? Cancer Cytopathol 2021;129(1):16–21. DOI: 10.1002/cncy.22322

12. Layfield L.J., Zhang T., Esebua M. Diagnostic sensitivity and risk of malignancy for bile duct brushings categorized by the Papanicolaou Society of Cytopathology System for reporting pancreaticobiliary cytopathology. Diagn Cytopathol 2022;50(1):24– 7. DOI: 10.1002/dc.24901

13. Nikas I.P., Proctor T., Seide S. et al. Diagnostic Performance of Pancreatic Cytology with the Papanicolaou Society of Cytopathology System: A Systematic Review, before Shifting into the Upcoming WHO International System. Int J Mol Sci 2022;23(3):1650. DOI: 10.3390/ijms23031650

14. Pitman M.B., Centeno B.A., Ali S.Z. et al. Papanicolaou Society of Cytopathology. Standardized terminology and nomenclature for pancreatobiliary cytology: the Papanicolaou Society of Cytopathology guidelines. Diagn Cytopathol 2014;42(4):338–50. DOI: 10.1002/dc.23092

15. Pitman M.B., Centeno B.A., Genevay M. et al. Grading epithelial atypia in endoscopic ultrasound-guided fine-needle aspiration of intraductal papillary mucinous neoplasms: an international interobserver concordance study. Cancer Cytopathol 2013;121(12):729–36. DOI: 10.1002/cncy.21334

16. Hoda R.S., Finer E.B., Arpin R.N. et al. Risk of malignancy in the categories of the Papanicolaou Society of Cytopathology system for reporting pancreaticobiliary cytology. J Am Soc Cytopathol 2019;8(3):120–7. DOI: 10.1016/j.jasc.2019.01.002

17. Sung S., Del Portillo A., Gonda T.A. et al. Update on risk stratification in the Papanicolaou Society of Cytopathology System for Reporting Pancreaticobiliary Cytology categories: 3-Year, prospective, single-institution experience. Cancer Cytopathol 2020;128(1):29–35. DOI: 10.1002/cncy.22199

18. Brugge W.R., Lewandrowski K., Lee-Lewandrowski E. et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004;126(5):1330–6. DOI: 10.1053/j.gastro.2004.02.013

19. Cizginer S., Turner B.G,, Bilge A,R, et al. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas 2011;40(7):1024–8. DOI: 10.1097/MPA.0b013e31821bd62f. Erratum in: Pancreas 2013;42(4):728.

20. Cizginer S., Turner B.G., Bilge A.R. et al. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas 2011;40(7):1024–8. DOI: 10.1097/MPA.0b013e31821bd62f. Erratum in: Pancreas 2013;42(4):728.

21. European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018;67(5):789–804. DOI: 10.1136/ gutjnl-2018-316027

22. Elta G.H., Enestvedt B.K., Sauer B.G., Lennon A.M. ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts. Am J Gastroenterol 2018;113(4):464–79. DOI: 10.1038/ajg.2018.14

23. Megibow A.J., Baker M.E., Morgan D.E. et al. Management of Incidental Pancreatic Cysts: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol 2017;14(7): 911–23. DOI: 10.1016/j.jacr.2017.03.010

24. Tanaka M., Fernández-del Castillo C., Adsay V. et al. International Association of Pancreatology. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12(3):183–97. DOI: 10.1016/j.pan.2012.04.004

25. Tanaka M., Fernández-Del Castillo C., Kamisawa T. et al. Revisions of International Consensus Fukuoka Guidelines for the Management of IPMN of the Pancreas. Pancreatology 2017;17(5):738–53. DOI: 10.1016/j.pan.2017.07.007

26. European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018;67(5):789–804. DOI: 10.1136/gutjnl-2018-316027

27. Vege S.S., Ziring B., Jain R. et al. American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts. Gastroenterology 2015;148(4):819–22. DOI: 10.1053/j.gastro.2015.01.015